Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database

The objective of this study was to evaluate glucocorticoid (GC) use in patients with polymyalgia rheumatica (PMR), giant cell arteritis (GCA) or both diseases (PMR + GCA) under rheumatological care. Data from patients with PMR ( n = 1420), GCA ( n = 177) or PMR + GCA ( n = 261) from the National...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology international 2018-04, Vol.38 (4), p.569-577
Hauptverfasser:	Albrecht, Katinka, Huscher, Dörte, Buttgereit, Frank, Aringer, Martin, Hoese, Guido, Ochs, Wolfgang, Thiele, Katja, Zink, Angela
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Autoimmune diseases Cohort Studies on Comorbidities Comorbidity Cross-Sectional Studies Databases, Factual Drug Administration Schedule Female Germany - epidemiology Giant Cell Arteritis - diagnosis Giant Cell Arteritis - drug therapy Giant Cell Arteritis - epidemiology Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Humans Logistic Models Longitudinal Studies Male Medicine Medicine & Public Health Multivariate Analysis Odds Ratio Osteoporosis Osteoporosis - chemically induced Osteoporosis - epidemiology Polymyalgia Rheumatica - diagnosis Polymyalgia Rheumatica - drug therapy Polymyalgia Rheumatica - epidemiology Prevalence Rheumatology Risk Factors Time Factors Treatment Outcome Vein & artery diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!